文献速递主动脉外科

TEVAR 术后远端支架诱导新发破口:15 年经验

Distal Stent Graft-Induced New Entry After TEVAR of Type B Aortic Dissection: Experience in 15 Years.
PubMed 文献 · Ann Thorac Surg · 2018-11-04

该研究回顾了 95 例 B 型主动脉夹层 TEVAR 后发生远端支架诱导新发破口(SINE)的患者,随访显示再干预(尤其是再 TEVAR)可显著改善 8 年生存率(88.3% vs 63.5%,p=0.001),但常规支架再 TEVAR 后 SINE 复发率高,更渐细的支架可能有助于预防复发。

要点

  • 再 TEVAR 较药物保守治疗显著改善 8 年生存率(88.3% vs 63.5%)。
  • 常规支架再 TEVAR 后 SINE 复发率 20%,6 年无复发生存率 56%。
  • 更渐细支架组无死亡及 SINE 复发。

核心结论

  • TEVAR 后远端 SINE 患者再干预可显著改善长期生存。
  • 常规支架再 TEVAR 后 SINE 复发率高,更渐细支架可能有助于预防复发。

研究设计与样本

  • 回顾性分析 95 例 TEVAR 后发生远端 SINE 的 TBAD 患者(年龄 53.2±10.9 岁,82 例男性)。
  • 随访率 100%,主要 TEVAR 术后随访 7.2±3 年。

主要发现

  • 远端 SINE 平均发生于主要 TEVAR 术后 2.7±2.4 年。
  • 78 例接受再 TEVAR(64 例常规支架,14 例更渐细支架),3 例手术,14 例药物;再 TEVAR 后 2 例死亡。
  • 随访 5.8±2.9 年,晚期死亡 19 例(药物 7 例,再 TEVAR 12 例);再 TEVAR 后 11 例 SINE 复发(3.5±1.7 年)。
  • 再干预较药物显著改善 8 年生存率(88.3% vs 63.5%,p=0.001)。
  • 常规支架组死亡率 24%,SINE 复发率 20%,6 年无复发生存率 56%;更渐细支架组无死亡及复发。

关键数值与推荐

  • 主要 TEVAR 后远端 SINE 的预测因素:支架长度(HR 0.984,p=0.037)和慢性期(HR 1.725,p=0.049)。

临床怎么用

  • TEVAR 后远端 SINE 应积极考虑再干预,再 TEVAR 可改善长期生存。
  • 再 TEVAR 时选用更渐细的支架可能降低 SINE 复发风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Experience is limited with distal stent graft-induced new entry (SINE) after thoracic endovascular aortic repair (TEVAR) of type B dissection (TBAD). We report the management strategy and outcomes in such patients. METHODS: Clinical data were analyzed for 95 patients (age, 53.2 ± 10.9 years; 82 men) who presented with distal SINE after TEVAR for TBAD. RESULTS: Follow-up was 100% for 7.2 ± 3 years after primary TEVAR. Distal SINE occurred at a mean of 2.7 ± 2.4 years. Re-TEVAR was performed for 78, with routine stent grafts in 64 and a more tapered graft in 14. Three patients were managed surgically and 14 medically. Two patients died after re-TEVAR. During follow-up at 5.8 ± 2.9 years, late death occurred in 19 patients, 7 with medical therapy and 12 with re-TEVAR. Distal SINE recurred in 11 at 3.5 ± 1.7 years after re-TEVAR. Reintervention significantly improved survival up to 8 years compared with medical therapy (88.3% vs 63.5%, p = 0.001). In 64 patients with routine stent grafts, mortality was 24%, distal SINE recurred in 20%, and recurrence-free survival was 56% at 6 years. Neither death nor recurrence of SINE occurred in 14 patients with a more tapered stent graft. Predictors for distal SINE after primary TEVAR were stent graft length (hazard ratio, 0.984; p = 0.037) and chronic phase (hazard ratio, 1.725; p = 0.049). CONCLUSIONS: In TBAD patients with distal SINE after TEVAR, reintervention with re-TEVAR could improve long-term survival significantly. Recurrence of distal SINE was high after re-TEVAR using routine stent grafts. More tapered stent grafts may be helpful in preventing the recurrence of distal SINE.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Li Q, Ma WG, Zheng J, et al. Distal Stent Graft-Induced New Entry After TEVAR of Type B Aortic Dissection: Experience in 15 Years. Ann Thorac Surg. 2018. PMID: 30403983. doi:10.1016/j.athoracsur.2018.09.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。